Data / Drug companies / Memantine hydrochloride
Memantine hydrochloride: 36 companies and 104 products in the FDA NDC directory
Memantine hydrochloride is listed in the FDA National Drug Code Directory by 36 companies, with 104 products in commercial distribution. 98 of the products (94.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, extended release; tablet, film coated, and the newest product started marketing on August 28, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 36
- Products
- 104
- Generic (ANDA) products
- 98 (94.2%)
- Application numbers
- 23
- Routes
- Oral
- Brand names
- Memantine
- openFDA record search
- api.fda.gov
Companies that list memantine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 7 | tablet; tablet, film coated | Generic drugs (ANDA) | September 26, 2022 |
| Macleods Pharmaceuticals Limited | 7 | capsule, extended release; tablet | Generic drugs (ANDA) | August 28, 2025 |
| Lupin Pharmaceuticals, Inc. | 6 | capsule, extended release; tablet, film coated | Generic drugs (ANDA) | February 20, 2018 |
| Zydus Lifesciences Limited | 6 | capsule, extended release; tablet, film coated | Generic drugs (ANDA) | April 8, 2018 |
| Aurobindo Pharma Limited | 5 | capsule, extended release; kit | Generic drugs (ANDA) | August 9, 2021 |
| Bryant Ranch Prepack | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | February 28, 2019 |
| Amneal Pharmaceuticals LLC | 4 | capsule, extended release | Generic drugs (ANDA) | December 22, 2017 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | February 28, 2019 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | February 28, 2019 |
| Cardinal Health 107, LLC | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | July 20, 2015 |
| Slate Run Pharmaceuticals, LLC | 4 | capsule, extended release | Generic drugs (ANDA) | November 15, 2021 |
| Vitruvias Therapeutics | 4 | capsule, extended release | Generic drugs (ANDA) | February 19, 2024 |
| Zydus Pharmaceuticals USA Inc. | 4 | capsule, extended release | Generic drugs (ANDA) | April 8, 2018 |
| Actavis Pharma, Inc. | 3 | tablet; kit | Authorized generics (NDA) | April 1, 2015 |
| Major Pharmaceuticals | 3 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | February 20, 2018 |
| Ajanta Pharma USA Inc. | 2 | tablet | Generic drugs (ANDA) | August 27, 2015 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, coated | Generic drugs (ANDA) | October 13, 2015 |
| Alembic Pharmaceuticals Limited | 2 | tablet, coated | Generic drugs (ANDA) | October 13, 2015 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | October 13, 2015 |
| AvPAK | 2 | tablet, film coated | Generic drugs (ANDA) | February 20, 2024 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | February 28, 2019 |
| Camber Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | September 26, 2022 |
| Carlsbad Technology, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 22, 2025 |
| Dr. Reddy's Laboratories Limited | 2 | tablet, film coated | Generic drugs (ANDA) | July 11, 2015 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 11, 2015 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | November 1, 2015 |
| Upsher-Smith Laboratories, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | July 31, 2015 |
| Viona Pharmaceuticals Inc | 2 | tablet | Generic drugs (ANDA) | February 28, 2019 |
| Apotex Corp. | 1 | solution | Generic drugs (ANDA) | April 30, 2018 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Generic drugs (ANDA) | October 13, 2015 |
| Chartwell RX, LLC | 1 | solution | Generic drugs (ANDA) | October 13, 2015 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | February 4, 2025 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | November 11, 2021 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | capsule, extended release | Generic drugs (ANDA) | August 9, 2021 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | January 20, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 34 | 32.7% |
| Capsule, extended release | 34 | 32.7% |
| Tablet, film coated | 26 | 25% |
| Tablet, coated | 4 | 3.8% |
| Solution | 4 | 3.8% |
| Kit | 2 | 1.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 98 | 94.2% |
| Authorized generics (NDA) | 5 | 4.8% |
| New drug applications (NDA) | 1 | 1% |
Pharmacologic classes
| Class | Products |
|---|---|
| N-methyl-D-aspartate Receptor Antagonist | 102 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.